JP Stock MarketDetailed Quotes

2160 GNI Group

Watchlist
  • 3175
  • +50+1.60%
20min DelayMarket Closed Jan 24 15:30 JST
159.28BMarket Cap19.18P/E (Static)

About GNI Group Company

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

Company Profile

Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees839
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ying Luo, PhD
  • Director, Representative Executive Officer, President and Chief Executive Officer
  • --
  • Toshiya Kitagawa
  • Director, Executive Officer and Chief Financial Officer
  • --
  • Sekitani Kazuki
  • Director, Executive Officer and Chief Operating Officer
  • --
  • Thomas Eastling
  • Director
  • --
  • Ryosuke Matsui
  • Director
  • --
  • Kikuchi Kanako
  • Independent Director
  • --
  • Zhang Ping
  • Independent Director
  • --
  • Hideaki Sashiwa
  • Independent Director
  • --
Top JP Stock Gainers
Symbol Price % Chg
Soiken Holdings
2385
169 +36.29%
GIG Works
2375
383 +26.40%
Note
5243
1021 +17.09%
Renascience
4889
1040 +16.85%
Reyuu Japan
9425
569 +16.36%

See the daily top gainer.